|
Volumn , Issue 3, 2008, Pages 58-63
|
Methodology of new pharmacoeconomic method "impact on hospital budget" by the example of local hemostatic agents in abdominal surgery
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APROTININ;
FIBRINOGEN;
HEMOSTATIC AGENT;
TACHOCOMB;
THROMBIN;
ARTICLE;
COST BENEFIT ANALYSIS;
DRUG COMBINATION;
ECONOMICS;
FINANCIAL MANAGEMENT;
HEALTH SERVICE;
HEMOSTASIS;
HOSPITAL COST;
HUMAN;
PERITONEAL CAVITY;
PHARMACOECONOMICS;
RUSSIAN FEDERATION;
SURGERY;
ABDOMINAL CAVITY;
APROTININ;
COST-BENEFIT ANALYSIS;
DRUG COMBINATIONS;
ECONOMICS, PHARMACEUTICAL;
FIBRINOGEN;
FINANCIAL MANAGEMENT, HOSPITAL;
HEALTH SERVICES;
HEMOSTASIS, SURGICAL;
HEMOSTATICS;
HOSPITAL COSTS;
HUMANS;
RUSSIA;
SURGICAL PROCEDURES, OPERATIVE;
THROMBIN;
|
EID: 44849083868
PISSN: 00231207
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|